Neurotoxicity Research

, Volume 2, Issue 1, pp 51–61 | Cite as

AMPA prevents glutamate-induced neurotoxicity and apoptosis in cultured cerebellar granule cell neurons

  • Krishna Banaudha
  • Ann M. MariniEmail author


Exposure of cultured cerebellar neurons to ±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) in the presence of aniracetam protects all of the vulnerable neurons against the excitotoxic actions of glutamate acting on N-methyl-D-aspartate receptors. The protective effect of AMPA was both time- and concentration-dependent. Aniracetam alone did not protect the neurons against the excitotoxic effects of glutamate. Pretreatment of cerebellar neurons with the AMPA antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione blocked the neuroprotective effect mediated by AMPA indicating that the neuroprotective effect is mediated specifically by AMPA receptors. An excitotoxic concentration of glutamate, which killed between 60–80% of granule cell neurons on day 8in vitro, mediated its toxic effect via a time-dependent apoptotic pathway. Pretreatment of cerebellar granule cell neurons with AMPA (500 μM) completely blocked glutamate-mediated apoptosis. Our results suggest that AMPA receptors may play an important role in neuronal survival.


AMPA Glutamate Excitotoxicity Cerebellar neurons Apoptosis Neuroprotection 



μ-amino-3-hydroxy-5-methyl-4-iso-xazolepropionic acid








Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ankarcrona, M., Dypbukt, J.M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S.A. and Nicotera, P. (1995) Glutamateinduced neuronal death: a succession of necrosis or apo-ptosis depending on mitochondrial function.Neuron 15: 961–73.PubMedCrossRefGoogle Scholar
  2. Ben-Ari, Y., Khazipov, R., Leinekugel, X., Caillard, O. and Gaiarsa, J.L. (1997) GABAA, NMDA and AMPA receptors: a developmentally regulated “menage a trois.”Trends Neurosci.20: 523–9.PubMedCrossRefGoogle Scholar
  3. Boxall, A.R. and Garthwaite, J. (1995) Synaptic excitation mediated by AMPA receptors in rat cerebellar slices is selectively enhanced by aniracetam and cyclothiazide.Neuwchem. Res. 20: 605–9.CrossRefGoogle Scholar
  4. Cebers, G. and Liljequist, S. (1995) Modulation of AMPA/ kainate receptors by cyclothiazide increases cytoplasmic free Ca2+ and45Ca2+ uptake in brain neurons.Eur. J. Pharmacol. 290: 105–15.PubMedCrossRefGoogle Scholar
  5. Choi, D.W. (1988) Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage.Trends Neurosci. 11: 465–9.PubMedCrossRefGoogle Scholar
  6. Copani, A., Genazzani, A.A., Aleppo, G., Casabona, G., Canonico, P.L., Scapagnini, U. and Nicoletti, F. (1992) Nootropic drugs positively modulate a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures.J. Neuwchem. 58: 1199–204.CrossRefGoogle Scholar
  7. Dessi, R, Charriaut-Marlangue, C, Khrestchatisky, M. and Ben-Ari, Y. (1993) Glutamate-induced neuronal death is not a programmed cell death in cerebellar culture.J. Neuwchem. 60: 1953–5.CrossRefGoogle Scholar
  8. Didier, M., Bursztajn, S., Adamec, E., Passani, L., Nixon, R.A., Coyle, J.T., Wei, J.Y. and Berman, S.A. (1996) DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures.J. Neurosci. 16: 2238–50.PubMedGoogle Scholar
  9. Dipasquale, B., Marini, A.M. and Youle, R.J. (1991) Apoptosis and DNA degradation induced by 1-methyl-4-phenyl-pyridinium in neurons.Biochem. Biophys. Res. Commun. 181: 1442–8.PubMedCrossRefGoogle Scholar
  10. Favaron, M., Manev, H., Alho, H., Bertolino, M., Ferret, B., Guidotti, A. and Costa, E. (1988) Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex.Proc. Natl. Acad. Sci. USA 85: 7351–5.PubMedCrossRefGoogle Scholar
  11. Gallo, V., Suiergiu, R., Giovannini, C. and Levi, G. (1987) Glutamate receptor subtypes in cultured cerebellar neurons: modulation of glutamate and gamma-aminobutyric acid release.J. Neuwchem. 49: 1801–9.CrossRefGoogle Scholar
  12. Giardina, S., Cheung, N.S., Reid, M.T. and Beart, P.M. (1998) Kainate-induced apoptosis in cultured murine cerebellar granule cells elevates expression of the cell cycle gene cyclin Dl.J. Neurochem. 71: 1325–8.PubMedGoogle Scholar
  13. Hack, N. and Balazs, R. (1995) Properties of AMPA receptors expressed in rat cerebellar granule cells in culture.J. Neurochem. 65: 1077–84.PubMedCrossRefGoogle Scholar
  14. Hayashi Sekiyama, N., Nakanishi, S., Jane, D.E., Sunter, D.C., Birse, E.F., Udvarhelyi, P.M. and Watkins, J.C. (1994) Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor subtypes.Neurosci. 14: 3370–7.Google Scholar
  15. Hoffman, P.L., Rabe, C.S., Moses, F. and Tabakoff, B. (1989) N-Methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production.J. Neurochem. 52: 1937–40.PubMedCrossRefGoogle Scholar
  16. Hollmann, M., O’Shea-Greenfield, A., Rogers, S.W. and Heinemann, S. (1989) Cloning by functional expression of a member of the glutamate receptor family.Nature 342: 643–8.PubMedCrossRefGoogle Scholar
  17. Jensen, J.B., Schousboe, A. and Pickering, D.S. (1998) Development of calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured neocortical neurons visualized by cobalt staining.J. Neurosci. Res. 54: 273–81.PubMedCrossRefGoogle Scholar
  18. Johansen, T.H., Chaudhary, A. and Verdoorn, T.A. (1995) Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.Mol. Pharmacol. 48: 946–55.PubMedGoogle Scholar
  19. Kato, K., Puttfarcken, P.S., Lyons, W.E. and Coyle, J.T. (1991) Developmental time course and ionic dependence of kainate-mediated toxicity in rat cerebellar granule cell cultures.J. Pharmacol. Exp. Ther. 256: 402–11.PubMedGoogle Scholar
  20. Keinanen, K., Wisden, W., Sommer, B., Werner, P., Herb, An., Verdoorn, T.A., Sakmann, B. and Seeburg, P.H. (1990) A family of AMPA-selective glutamate receptors.Science 249: 556–60.PubMedCrossRefGoogle Scholar
  21. Lee, J.-M., Zipfel, G.J. and Choi, D.W. (1999) The changing landscape of ischaemic brain injury mechanisms.Nature 399(Suppl.): A7-A14.PubMedGoogle Scholar
  22. Longone, P., Impagnatiello, R, Mienville, J.M., Costa, E. and Guidotti, A. (1998) Changes in AMPA receptor-spliced variant expression and shift in AMPA receptor spontaneous desensitization pharmacology during cerebellar granule cell maturationin vitro.J. Mol. Neurosci. 11: 23–41.PubMedCrossRefGoogle Scholar
  23. Liao, D., Hessler, N.A. and Malinow, R. (1995) Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice.Nature 375: 400–04.PubMedCrossRefGoogle Scholar
  24. Marini, A.M. and Novelli, A. (1991) The glutamate uptake blocker DL-threo-3-hydroxyaspartate reduces NMDA receptor activation by glutamate in cultured neurons.European J. Pharmacol. 194: 131–2.CrossRefGoogle Scholar
  25. Marini, A.M. and Paul, S.M. (1992) N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis.Proc. Natl. Acad. Sci. 89: 6555–9.PubMedCrossRefGoogle Scholar
  26. Marini, A.M., Rabin, S.J., Lipsky, R.H. and Mocchetti, I. (1998) Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate.J. Biol. Chem. 273: 29394–9.PubMedCrossRefGoogle Scholar
  27. Marini, A.M., Ueda, Y and June, C.H. (1999) Intracellular survival pathways: The role of intracellular calcium.New York Academy of Sciences.890: 421–437.CrossRefGoogle Scholar
  28. Muller, D. and Lynch, G. (1988) Long-term potentiation differentially affects two components of synaptic responses in hippocampus.Proc. Natl. Acad. Sci. USA 85: 9346–50.PubMedCrossRefGoogle Scholar
  29. Murphy, S.N. and Miller, J.R. (1989) Regulation of Ca++ influx into striatal neurons by kainic acid.J. Pharmacol. Exp. Ther. 249: 184–93.PubMedGoogle Scholar
  30. Nicoletti, R, Bruno, V, Catania, M.V., Battaglia, G., Copani, A., Barbagallo, G., Cena, V., Sanches-Prieto, J., Spano, P.F. and Pizzi, M. (1999) Group-I metabotropic glutamate recepors: hypotheses to explain their dual role in neurotoxicity and neuroprotection.Neuropharmacology 38: 1477–84.PubMedCrossRefGoogle Scholar
  31. Novelli, A., Reilly J.A., Lysko, P.G. and Henneberry, R.C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced.Brain Res. 451: 205–12.PubMedCrossRefGoogle Scholar
  32. Olney, J.W., Ho, O.L. and Rhee, V. (1971) Cytotoxic effects of acidic and sulphur-containing amino acids on the infant mouse central nervous system.Exp. Brain Res. 14: 61–76.PubMedCrossRefGoogle Scholar
  33. Partin, K.M., Fleck, M.W. and Mayer, M.L. (1996) AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate.J. Neurosci. 16: 6634–47.PubMedGoogle Scholar
  34. Perez-Pinzon, M.A., Maier, CM., Yoon, E.J., Sun, G.H., Giffard, R.G. and Steinberg, G.K. (1995) Correlation of CGS 19755 neuroprotection againstin vitro excitotoxicity and focal cerebral ischemia.J. Cereb. Blood Flow Metab. 15: 865–76.PubMedGoogle Scholar
  35. Pizzi, M., Fallacara, C, Arrighi, V., Memo, M. and Spano, P.F. (1993) Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells.J. Neurochem. 61: 683–9.PubMedGoogle Scholar
  36. Pruss, R.M., Akeson, R.C., Racke, M.M. and Wilburn, J.L. (1991) Agonist activated cobalt identifies divalent cation-permeable kainate receptors on neurons and glial cells.Neuron 7: 509–18.PubMedCrossRefGoogle Scholar
  37. Schoepp, D.D., Jane, D.E. and Monn, J.A. (1999) Pharmacological agents acting at subtypes of metabotropic glutamate receptors.Neuropharmacology 38: 1431–76.PubMedCrossRefGoogle Scholar
  38. Sheardown, M.J., Nielsen, E.O., Hansen, A.J., Jacobsen, P. and Honore, T. (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo-(F)quinoxaline: a neuroprotectant for cerebral ischemia.Science 247: 571–4.PubMedCrossRefGoogle Scholar
  39. Shi, S.-H., Hayashi, Y., Petralia, R.S., Zaman, S.H., Wenthold, R.J., Svoboda, K. and Malinow, R. (1999) Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation.Science 284: 1811–16.PubMedCrossRefGoogle Scholar
  40. Swanson, G.T., Kamboj, S.K. and Cull-Candy, S.G. (1997) Single-channel properties of recombinant AMPA receptors depend on RNA editing, splice variation, and subunit composition.J. Neurosci. 17: 58–69.PubMedGoogle Scholar
  41. Yamada, K.A. (1998) Modulating exciatory synaptic neurotransmission: potential treatment for neurological disease?Neurobiol. Dis. 5: 67–80.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2000

Authors and Affiliations

  1. 1.Department of NeurologyUniformed Services University of the Health SciencesBethesdaUSA

Personalised recommendations